Cancer CXC chemokine networks and tumour angiogenesis
Top Cited Papers
- 1 April 2006
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (6), 768-778
- https://doi.org/10.1016/j.ejca.2006.01.006
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8American Journal of Physiology-Heart and Circulatory Physiology, 2005
- NF‐κB activity blockade impairs the angiogenic potential of human pancreatic cancer cellsInternational Journal of Cancer, 2003
- NF-κB, chemokine gene transcription and tumour growthNature Reviews Immunology, 2002
- Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localizationEuropean Journal of Immunology, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Angiogenesis inhibitors. A promising role in cancer therapy.Cancer Practice, 1998
- Tumorangiogenesis: A Network of CytokinesKlinische Padiatrie, 1997
- The Functional Role of the ELR Motif in CXC Chemokine-mediated AngiogenesisJournal of Biological Chemistry, 1995
- Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.The Journal of Experimental Medicine, 1994
- Angiogenesis. State of the artChest, 1988